Glypican-3 (GPC3) signaling pathway involved in breast cancer progression

被引：0
|
作者：
Fernandez, Dolores [1 ]
Cercato, Magali [1 ]
Guereno, Macarena [1 ]
Peters, Maria G. [1 ]
机构：
[1] Angel H Roffo Inst Oncol, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4508
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Expression of Glypican-3 in Colorectal Cancer
    Azizpour, Sonia
    Ezati, Razieh
    Saidijam, Massoud
    Razavi, Amirnader Emami
    Jalilian, Farid Azizi
    Mahdavinezhad, Ali
    Eslami, Hamid
    Soltanian, Alireza
    Mohammadpour, Hadiseh
    Kamali, Fatemeh
    Amini, Razieh
    CYTOLOGY AND GENETICS, 2019, 53 (05) : 430 - 440
  • [42] The Expression of Glypican-3 in Colorectal Cancer
    Sonia Azizpour
    Razieh Ezati
    Massoud Saidijam
    Amirnader Emami Razavi
    Farid Azizi Jalilian
    Ali Mahdavinezhad
    Hamid Eslami
    Alireza Soltanian
    Hadiseh Mohammadpour
    Fatemeh Kamali
    Razieh Amini
    Cytology and Genetics, 2019, 53 : 430 - 440
  • [43] Glypican 3 (GPC3)-CD81 axis in regulation Hippo pathway in hepatocytes and hepatocellular carcinoma (HCC)
    Xue, Yuhua
    Koral, Kelly
    Bowen, William C.
    Orr, Anne
    Haynes, Meagan
    Mars, Wendy M.
    Michalopoulos, George K.
    HEPATOLOGY, 2015, 62 : 1171A - 1172A
  • [44] In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells
    Boily, Gino
    Ouellet, Stephane
    Langlois, Sylvie
    Lariviere, Mathieu
    Drouin, Regen
    Sinnett, Daniel
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2007, 1769 (03): : 182 - 193
  • [45] Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model
    Peters, MG
    Farías, E
    Colombo, L
    Filmus, J
    Puricelli, L
    Joffé, EBD
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (02) : 221 - 232
  • [46] Inhibition of Invasion and Metastasis by Glypican-3 in a Syngeneic Breast Cancer Model
    M.G. Peters
    E. Farías
    L. Colombo
    J. Filmus
    L. Puricelli
    E. Bal de Kier Joffé
    Breast Cancer Research and Treatment, 2003, 80 : 221 - 232
  • [47] Glypican-3 (GPC3), a Heparan Sulfate Proteoglycan Associated with the Simpson-Golabi-Behmel Fetal Overgrowth Syndrome, Is Expressed by the Syncytiotrophoblast in the Human Placenta
    Shaista Khan
    Reid Huber
    David Schlessinger
    Michael Fant
    Pediatric Research, 1999, 45 : 54 - 54
  • [48] Glypican 3 (GPC3), CD81 and HCV E2 protein control Yap and Hippo Pathway
    Xue, Yuhua
    Bown, Bill
    Orr, Anne
    Koral, Kelly
    Haynes, Meagan
    Mars, Wendy
    Michalopoulos, George
    FASEB JOURNAL, 2016, 30
  • [49] Glypican 3 (GPC3) induces senescence and reduces cell migration by inhibiting the Canonical Wnt pathway in mammary adenocarcinoma cells
    Buchanan, Cecilia
    Garay-Malpartida, Humberto
    Puricelli, Lydia
    Sogayar, Mari
    de Kier Joffe, Elisa Bal
    Peters, Maria
    CANCER RESEARCH, 2009, 69
  • [50] Glypican-3 (GPC3), a heparan sulfate proteoglycan associated with the Simpson-Golabi-Behmel fetal overgrowth syndrome, is expressed by the syncytiotrophoblast in the human placenta
    Khan, S
    Huber, R
    Schlessinger, D
    Fant, M
    PEDIATRIC RESEARCH, 1999, 45 (04) : 54A - 54A
12345